CLINICAL TRIALS PROFILE FOR SYNERCID
✉ Email this page to a colleague
All Clinical Trials for SYNERCID
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00240747 ↗ | Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients | Terminated | Aventis Pharmaceuticals | Phase 3 | 2000-06-01 | Open-label, multicenter, multiple-dose, study of population pharmacokinetics of I.V. Synercid (7.5 mg/kg every 8 hours) in 75 pediatric patients. The purpose is to assess the population pharmacokinetics of Synercid in pediatric patients and to collect additional safety and efficacy data in pediatric patients. |
NCT00240747 ↗ | Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients | Terminated | Pfizer | Phase 3 | 2000-06-01 | Open-label, multicenter, multiple-dose, study of population pharmacokinetics of I.V. Synercid (7.5 mg/kg every 8 hours) in 75 pediatric patients. The purpose is to assess the population pharmacokinetics of Synercid in pediatric patients and to collect additional safety and efficacy data in pediatric patients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SYNERCID
Condition Name
Clinical Trial Locations for SYNERCID
Trials by Country
Clinical Trial Progress for SYNERCID
Clinical Trial Phase
Clinical Trial Sponsors for SYNERCID
Sponsor Name